MDaudit Wins 2025 FinTech Award for Healthcare Financial Solutions

April 23, 2025 9:00 AM

MDaudit, an award-winning cloud-based continuous risk monitoring platform for RCM that enables the nation's premier healthcare organizations to minimize billing risks and maximize revenues, has been named a winner in The 2025 FinTech Awards program. The company earned top honors in the healthcare and pharmaceutical category for its AI-powered platform, which features innovative tools like AI Assist and Smartscan.ai to help healthcare...

Read more

Compremium AG Appoints Dr. Kolaleh Eskandanian to Lead New Division of Pediatrics and Special Populations

April 23, 2025 8:30 AM

Compremium AG, a pioneering Swiss medical technology company, announced today the appointment of Kolaleh Eskandanian, PhD, MBA, as Chief Strategy and Innovation Officer and Head of its newly formed Division of Pediatrics and Special Populations.Kolaleh Eskandanian, PhD, MBA Dr. Eskandanian, a global leader in pediatric innovation, joins Compremium from Children's National Hospital in Washington, D.C., where she most recently served as Vice...

Read more

Ambience Healthcare’s AI Platform for Documentation, CDI, and Coding Now Available in Microsoft Azure Marketplace

April 23, 2025 8:05 AM

Ambience Healthcare, a leader in ambient AI technology, today announced the availability of Ambience's AI platform for health systems in Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. Ambience Healthcare customers can now take advantage of the productive and trusted Azure cloud platform, with streamlined deployment and management.Ambience is a single, unified solution for health systems that...

Read more

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

April 23, 2025 8:00 AM

Ainos, Inc. (Nasdaq:AIMD)(Nasdaq:AIMDW) ("Ainos"), a leader in AI-powered scent digitization, today announced that Water Tower Research ("WTR") has published a report highlighting the Company's successful installation of its AI Nose technology onto a humanoid robot developed by ugo, Inc., Japan's leading service robot company. The milestone, achieved just weeks after announcing the partnership, demonstrates fast execution and marks a global...

Read more

MIRA Pharmaceuticals Reports Positive In Vitro Drug Release Data for Topical Ketamir-2, Targeting $11B+ U.S. Topical Pain Relief Market and Exploring FDA Fast Track Designation

April 23, 2025 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA, a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic and neuropsychiatric disorders, today announced the completion of in vitro release testing (IVRT) for its topical formulation of Ketamir-2. The formulation is under investigation for localized application in pain-related conditions.The IVRT study assessed a 5% ointment formulation of Ketamir-2 using a...

Read more

Ensysce Biosciences Receives U.S. Patent for Groundbreaking Treatment of Opioid Use Disorder

April 23, 2025 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for abuse and overdose, today announced it received a Notice of Allowance from the U.S. Patent and Trademark Office for the issuance of a patent entitled: Enzyme-Cleavable Methadone Prodrugs and Methods of Use Thereof¹ including both composition of matter...

Read more

A Place to Heal: Virtue Recovery Center Stands With Veterans and Families Across the United States

April 23, 2025 7:00 AM

When military service ends, many Veterans find themselves facing a new kind of battle - one marked by PTSD, addiction, and the struggle to reconnect with daily life. With an average of 17 Veterans lost to suicide every day, Virtue Recovery Center is stepping in with a mission grounded in compassion, trust, and real support.Cookie-cutter solutions don't work for those who've faced the intense pressures of service, loss, or combat. That's why...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Secures Record $1M+, 480-Unit Wattbike Order from US Distributor, WOODWAY

April 23, 2025 7:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Wattbike and Sportstech, today announced it has secured a record order for 480 bikes, comprising the new Air Pro and Atom X models, from the US distributor, Woodway. This order builds on TRNR and Wattbike's momentum from the recently announced Wattbike acquisition and...

Read more

BioNxt Solutions Prepares for Human Bioequivalence Study For MS

April 23, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment.BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal...

Read more

Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024

April 22, 2025 6:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2024 Year End Financial Results via conference call on April 29, 2025 at 8:30 am Eastern Time. The 2024 Year End Financials will be filed after market close on April 28, 2025.Conference Call...

Read more

Dr. James Orbinski Joins Onco-Innovations' Scientific and Clinical Advisory Board to Bolster Company's Mission

April 22, 2025 6:00 PM

Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF) (Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Dr. James Orbinski as a member of the Company's Scientific and Clinical Advisory Board.A former International President of Médecins Sans Frontières/Doctors Without Borders (MSF), Dr. Orbinski accepted the Nobel Peace Prize on behalf of MSF in 1999. He has provided medical humanitarian relief in complex...

Read more

Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

April 22, 2025 4:05 PM

Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, announced the closing of its previously announced offering of 2,324,000 shares of the Company's common stock in a registered direct offering (the "offering") at a purchase price of $0.862 per share.Roth Capital...

Read more

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

April 22, 2025 4:01 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the registration of its hypochlorous acid-based acne products with the Medicines & Healthcare products Regulatory...

Read more

Solv Wellness(R), the Pioneers of Clinically Proven UTI Prevention, Introduces GennaMD(TM): The Next Generation of UTI Defense(TM)

April 22, 2025 4:00 PM

Solv Wellness, a leader in women's menopause and pelvic health, is proud to announce the launch of GennaMD, its latest innovation in urinary tract infection (UTI) management. Building on its legacy as the first company to introduce a clinically proven 36 mg PAC (proanthocyanidin) cranberry supplement to the US market in 2010, Solv Wellness is setting the new standard for UTI management with GennaMD.For the last 15 years, Solv Wellness has been...

Read more

Full Alliance Group, Inc. (OTC: FAGI) Establishes Aquaox Pure Solutions, LLC to Revolutionize Hypochlorous Acid Production with Nanobubble Technology

April 22, 2025 2:25 PM

Full Alliance Group, Inc. (OTC:FAGI) today announced the formation of its wholly owned subsidiary, Aquaox Pure Solutions, LLC. The new entity will manufacture pure hypochlorous acid (HOCl) utilizing advanced nanobubble technology, positioning the company to set new standards in efficacy and safety across multiple industries including healthcare, agriculture, water treatment, and consumer products.Michel Van Schaik, a globally recognized expert...

Read more

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

April 22, 2025 1:55 PM

Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men's performance, health, and vitality. Its pursuit comes at a time when opportunities have become enormous, with patent expirations on several of the world's most popular health and wellness drugs, opening vast pathways to exploit segmented market opportunities, each worth billions.To get a deeper understanding of how Mangoceuticals Inc. intends to capture its share...

Read more

CS Group Announces the Valuation of MEDUSA Surface Disinfectant at USD 513 Million

April 22, 2025 10:00 AM

CS Group announced the completion of a comprehensive valuation for its proprietary smart surface disinfectant, MEDUSA. The valuation conducted as of April 1, 2025 estimates the fair market value of these rights at USD 513 Million reflecting the significant growth potential and competitive advantages of the MEDUSA product line.CS Group is advancing discussions with healthcare providers, facilities management companies, and distribution partners...

Read more

Biomedical HIV Prevention Summit in Atlanta Is the Focus To Drive Meaningful Action With Gilead Sciences

April 22, 2025 9:20 AM

This year's Biomedical HIV Prevention Summit in Atlanta emphasized the importance of advancing prevention in the U.S. South, a region disproportionately impacted by HIV. We joined advocates, community partners and healthcare leaders to discuss the future of prevention and to drive meaningful action - and the energy in the room was palpable. By working closely with the communities most affected, we aim to ensure everyone receives the care and...

Read more

CK Life Sciences' Investigational Cancer Vaccines Deliver Promising Results - New Preclinical Study Data to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting

April 22, 2025 8:15 AM

CK Life Sciences Int'l., (Holdings) Inc. ("the Company") announced that the Company will be presenting new data from its cancer vaccine research pipeline at the 2025 American Association for Cancer Research (AACR) Annual Meeting in Chicago, USA.The AACR Annual Meeting is a gathering central to the global cancer research community, bringing together scientists, clinicians, other healthcare professionals, survivors, patients and advocates every...

Read more

Diversified Private Markets Launches The Medicare Store to Transform Employee Benefits and Medicare Market

April 22, 2025 8:15 AM

Diversified Private Markets (DPM), a leading provider of employee benefits consulting, private financial investment in small businesses, along with Medicare sales and marketing solutions, has announced the launch of The Medicare Store, offering a groundbreaking approach to Medicare education and enrollment.The Medicare Store is dedicated to helping businesses integrate Medicare education into their employee benefits offerings. By delivering...

Read more